Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com.

Share

Key dates

  • Early Bird Registrations Open

    Friday, 22 March 2024

  • Abstract Submissions Open

    Friday, 22 March 2024

  • Abstract Submissions Close

    Tuesday, 23 July 2024

  • Volunteer Applications Close

    Wednesday, 21 August 2024

  • Abstract Acceptance Notification

    Wednesday, 7 August 2024

  • Early Bird Registration Deadline

    Friday, 23 August 2024

  • Speaker Registration Deadline

    Monday, 23 September 2024

  • Standard Registration Deadline

    Thursday, 7 November 2024

More Partners / Exhibitors